Shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Get Free Report) have been assigned a consensus recommendation of “Hold” from the four analysts that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $36.00.
Several research analysts have weighed in on the company. StockNews.com started coverage on Nu Skin Enterprises in a report on Thursday, May 18th. They issued a “hold” rating for the company. Stifel Nicolaus reduced their price target on shares of Nu Skin Enterprises from $43.00 to $35.00 and set a “hold” rating on the stock in a research report on Wednesday. Finally, DA Davidson dropped their price objective on shares of Nu Skin Enterprises from $38.00 to $29.00 and set a “neutral” rating on the stock in a research note on Thursday.
Nu Skin Enterprises Stock Performance
Shares of NUS stock opened at $26.24 on Wednesday. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 18.61 and a beta of 1.17. Nu Skin Enterprises has a 1 year low of $26.19 and a 1 year high of $47.31. The stock’s 50-day moving average is $31.69 and its two-hundred day moving average is $37.30. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.09 and a current ratio of 2.08.
Nu Skin Enterprises Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 6th. Stockholders of record on Friday, August 25th will be issued a dividend of $0.39 per share. The ex-dividend date is Thursday, August 24th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 5.95%. Nu Skin Enterprises’s dividend payout ratio is currently 110.64%.
Insider Buying and Selling
In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of the business’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $28.99, for a total value of $57,980.00. Following the transaction, the director now directly owns 58,625 shares in the company, valued at $1,699,538.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, Director Andrew D. Lipman sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $28.99, for a total value of $57,980.00. Following the completion of the transaction, the director now owns 58,625 shares in the company, valued at $1,699,538.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Edwina D. Woodbury sold 1,255 shares of the stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $37.87, for a total transaction of $47,526.85. Following the transaction, the director now owns 15,469 shares of the company’s stock, valued at approximately $585,811.03. The disclosure for this sale can be found here. Insiders have sold 7,255 shares of company stock worth $238,307 in the last quarter. 2.00% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Nu Skin Enterprises
A number of hedge funds have recently bought and sold shares of NUS. Eagle Bay Advisors LLC grew its stake in shares of Nu Skin Enterprises by 37.1% in the 2nd quarter. Eagle Bay Advisors LLC now owns 809 shares of the company’s stock worth $35,000 after acquiring an additional 219 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Nu Skin Enterprises by 1.5% in the second quarter. Price T Rowe Associates Inc. MD now owns 20,205 shares of the company’s stock valued at $875,000 after purchasing an additional 292 shares in the last quarter. Inspire Investing LLC grew its position in Nu Skin Enterprises by 1.8% during the fourth quarter. Inspire Investing LLC now owns 17,351 shares of the company’s stock valued at $732,000 after acquiring an additional 307 shares during the last quarter. Envestnet Asset Management Inc. grew its position in Nu Skin Enterprises by 3.7% during the fourth quarter. Envestnet Asset Management Inc. now owns 9,465 shares of the company’s stock valued at $399,000 after acquiring an additional 339 shares during the last quarter. Finally, Raymond James & Associates grew its holdings in shares of Nu Skin Enterprises by 3.9% in the first quarter. Raymond James & Associates now owns 9,829 shares of the company’s stock worth $386,000 after purchasing an additional 366 shares during the last quarter. 89.06% of the stock is owned by institutional investors.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products.
Featured Stories
- Five stocks we like better than Nu Skin Enterprises
- Conference Calls and Individual Investors
- 3 Best Meme ETFs to Buy Now
- Compound Interest and Why It Matters When Investing
- XPO Keeps Reaching New Highs: Markets Love the Stock
- Investing in Agriculture 101: How to Invest in Agriculture
- Starbucks Market at a Turning Point: Is a Breakout Imminent?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.
